Understanding and Operationalizing A Complex Adaptive Design
A clinical-stage biopharmaceutical company came to Veristat with a complex statistical methodology for running a phase II adaptive design trial with the goal of expediting a go/no-go decision for a specific patient population.
Case Study
Veristat Works Well with Growing Firms
We are more than just your typical boutique "CRO" that caters to growing firms. Meet us and consider why you should speak with Veristat for the design and implementation of your clinical trials and regulatory submissions.
Case Study
Writing Multiple Marketing Applications At The Same Time
A mid-size pharmaceutical company and its development partner, a small biotechnology company engaged Veristat to complete the medical writing for their product’s Marketing Authorization Application (MAA), New Drug Application (NDA), and New Drug Submission (NDS).
Case Study
